Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Kenter

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Research|August 4, 2004
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6Annemieke de Jong, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.
BMC Cancer|November 5, 2015
From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancerCharlotte Ngo, Sanne Samuels, Ksenia Bagrintseva, et al.
Plos One|July 14, 2018
Human papillomavirus (HPV) prevalence and associated risk factors in women from CuraçaoDesiree J Hooi, Birgit I Lissenberg-Witte, Gemma Kenter, et al.
Cancer Research|January 26, 2002
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjectsAnnemieke de Jong, Sjoerd H van der Burg, Kitty M C Kwappenberg, et al.
Gynecologic Oncology|September 5, 2012
Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasisDavid Cibula, Nadeem R Abu-Rustum, Ladislav Dusek, et al.
The Lancet. Oncology|November 11, 2018
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsIgnace Vergote, Corneel Coens, Matthew Nankivell, et al.
Cancer Research|February 5, 2003
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounterMarij J P Welters, Annemieke de Jong, Susan J F van den Eeden, et al.
Nature Medicine|December 5, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersWouter Scheper, Sander Kelderman, Lorenzo F Fanchi, et al.
Ebiomedicine|October 23, 2020
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancerSuzy M Scholl, Jonas Beal, Leanne de Koning, et al.
British Journal of Cancer|November 16, 2020
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Research|August 4, 2004
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6Annemieke de Jong, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.
BMC Cancer|November 5, 2015
From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancerCharlotte Ngo, Sanne Samuels, Ksenia Bagrintseva, et al.
Plos One|July 14, 2018
Human papillomavirus (HPV) prevalence and associated risk factors in women from CuraçaoDesiree J Hooi, Birgit I Lissenberg-Witte, Gemma Kenter, et al.
Cancer Research|January 26, 2002
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjectsAnnemieke de Jong, Sjoerd H van der Burg, Kitty M C Kwappenberg, et al.
Gynecologic Oncology|September 5, 2012
Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasisDavid Cibula, Nadeem R Abu-Rustum, Ladislav Dusek, et al.
The Lancet. Oncology|November 11, 2018
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsIgnace Vergote, Corneel Coens, Matthew Nankivell, et al.
Cancer Research|February 5, 2003
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounterMarij J P Welters, Annemieke de Jong, Susan J F van den Eeden, et al.
Nature Medicine|December 5, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersWouter Scheper, Sander Kelderman, Lorenzo F Fanchi, et al.
Ebiomedicine|October 23, 2020
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancerSuzy M Scholl, Jonas Beal, Leanne de Koning, et al.
British Journal of Cancer|November 16, 2020
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
Pageof 3